BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18729812)

  • 1. Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cells.
    Blagosklonny MV
    Rejuvenation Res; 2008 Aug; 11(4):801-8. PubMed ID: 18729812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin for aging stem cells.
    Hambright WS; Philippon MJ; Huard J
    Aging (Albany NY); 2020 Aug; 12(15):15184-15185. PubMed ID: 32756013
    [No Abstract]   [Full Text] [Related]  

  • 3. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.
    Blagosklonny MV
    Cell Cycle; 2006 Sep; 5(18):2087-102. PubMed ID: 17012837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mechanisms and Potential Impact of Stem Cell Activation in Skin Rejuvenation: An Evidence-Based Analysis.
    Sundaram H
    J Drugs Dermatol; 2017 Apr; 16(4):378-384. PubMed ID: 28403273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle stem cell aging: regulation and rejuvenation.
    Sousa-Victor P; García-Prat L; Serrano AL; Perdiguero E; Muñoz-Cánoves P
    Trends Endocrinol Metab; 2015 Jun; 26(6):287-96. PubMed ID: 25869211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From rapalogs to anti-aging formula.
    Blagosklonny MV
    Oncotarget; 2017 May; 8(22):35492-35507. PubMed ID: 28548953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rejuvenation of aged stem cells for cardiac repair.
    Ludke A; Li RK; Weisel RD
    Can J Cardiol; 2014 Nov; 30(11):1299-306. PubMed ID: 25092405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation.
    Madonna R; Engel FB; Davidson SM; Ferdinandy P; Gorbe A; Sluijter JP; Van Laake LW
    Curr Drug Targets; 2015; 16(8):780-5. PubMed ID: 25479545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin and mTOR inhibitors probably have therapeutic effects for post-operative cognitive dysfunction.
    Yang C; Zhu B; Shen J; Hu T; Li Z; Hong T
    Med Hypotheses; 2013 Sep; 81(3):487-8. PubMed ID: 23850396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin: the cure for all that ails.
    Hasty P
    J Mol Cell Biol; 2010 Feb; 2(1):17-9. PubMed ID: 19805415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Watch your notch: a link between aging and stem cell fate?
    Stolzing A; Sethe S
    Rejuvenation Res; 2004; 7(1):9-11. PubMed ID: 15256040
    [No Abstract]   [Full Text] [Related]  

  • 12. mTOR in aging, metabolism, and cancer.
    Cornu M; Albert V; Hall MN
    Curr Opin Genet Dev; 2013 Feb; 23(1):53-62. PubMed ID: 23317514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin as an antiaging therapeutic?: targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases.
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2011 Aug; 14(4):437-41. PubMed ID: 21851176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective treatment of age-related diseases by slowing down aging.
    Blagosklonny MV
    Am J Pathol; 2012 Oct; 181(4):1142-6. PubMed ID: 22841821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells and molecular advances in the treatment of facial skin.
    Sclafani AP
    Facial Plast Surg Clin North Am; 2013 Feb; 21(1):77-80. PubMed ID: 23369591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease.
    Santos RX; Correia SC; Cardoso S; Carvalho C; Santos MS; Moreira PI
    J Neurochem; 2011 Jun; 117(6):927-36. PubMed ID: 21447003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deconstructing mTOR complexes in regulation of Glioblastoma Multiforme and its stem cells.
    Jhanwar-Uniyal M; Jeevan D; Neil J; Shannon C; Albert L; Murali R
    Adv Biol Regul; 2013 May; 53(2):202-10. PubMed ID: 23231881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Problems: A perspective on stem cell aging and rejuvenation.
    Conboy IM; Conboy MJ; Rebo J
    Aging (Albany NY); 2015 Oct; 7(10):754-65. PubMed ID: 26540176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progeria, rapamycin and normal aging: recent breakthrough.
    Blagosklonny MV
    Aging (Albany NY); 2011 Jul; 3(7):685-91. PubMed ID: 21743107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic renal cell carcinoma: role of mammalian target of rapamycin inhibitors.
    Bukowski RM
    Clin Genitourin Cancer; 2007 Sep; 5(6):359-61. PubMed ID: 17956708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.